The germinal Center B-cell signature is associated to a higher [18F]-FDG uptake and improves the prognosis value of TEP scan in diffuse large B-celle lymphomas (DLBCL) treated by rituximab(R) and anthracyclines-based chemotherapy.
ANNALS OF ONCOLOGY（2011）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要